CINECA IRIS Institutional Research Information System

BASILE, Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.265
EU - Europa 1.626
AS - Asia 948
SA - Sud America 187
OC - Oceania 41
AF - Africa 36
Totale 5.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.181
IT - Italia 515
CN - Cina 321
SG - Singapore 188
DE - Germania 187
JP - Giappone 138
IE - Irlanda 131
FR - Francia 109
SE - Svezia 89
BR - Brasile 78
ES - Italia 72
TR - Turchia 66
DK - Danimarca 57
GB - Regno Unito 55
PL - Polonia 55
CA - Canada 47
AR - Argentina 46
FI - Finlandia 46
UA - Ucraina 44
VN - Vietnam 43
AT - Austria 42
IN - India 41
RU - Federazione Russa 38
AU - Australia 36
HU - Ungheria 35
CO - Colombia 33
HK - Hong Kong 30
MX - Messico 29
BE - Belgio 28
ID - Indonesia 27
KR - Corea 26
CH - Svizzera 20
GR - Grecia 19
NL - Olanda 18
PT - Portogallo 17
TW - Taiwan 16
DZ - Algeria 15
IL - Israele 12
CL - Cile 10
HR - Croazia 10
PE - Perù 9
BA - Bosnia-Erzegovina 7
EC - Ecuador 7
TH - Thailandia 7
MY - Malesia 6
RS - Serbia 6
TN - Tunisia 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
PH - Filippine 5
SI - Slovenia 5
DO - Repubblica Dominicana 4
JO - Giordania 4
NZ - Nuova Zelanda 4
RO - Romania 4
SY - Repubblica araba siriana 4
VE - Venezuela 4
OM - Oman 3
PK - Pakistan 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
CU - Cuba 2
IR - Iran 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
SA - Arabia Saudita 2
SN - Senegal 2
UZ - Uzbekistan 2
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
FJ - Figi 1
LT - Lituania 1
LU - Lussemburgo 1
ME - Montenegro 1
MU - Mauritius 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.103
Salva come PNG Salva come JPEG
Città #
Chandler 242
Singapore 166
Ann Arbor 139
Santa Clara 139
Fairfield 137
Dublin 125
Beijing 111
Ashburn 93
Torino 91
Woodbridge 79
Seattle 68
Cambridge 67
Redwood City 67
Wilmington 61
Houston 60
Turin 52
Nyköping 49
Jacksonville 42
Munich 39
Columbus 34
Vienna 33
Guangzhou 29
Medford 29
Jakarta 27
Princeton 27
Dong Ket 26
Würzburg 26
Shanghai 25
Buenos Aires 22
Villeurbanne 22
Los Angeles 21
Milan 21
Okazaki 21
Rochester 21
Bogotá 20
Pisa 20
Budapest 19
Fremont 19
Istanbul 18
New York 18
Paris 18
Hefei 17
Dearborn 16
Ankara 15
Florence 15
Tokyo 15
Rome 14
Lappeenranta 13
Taipei 13
Moscow 12
Rio de Janeiro 12
Boston 11
Brisbane 11
Fukuoka 11
Helsinki 11
Seoul 11
Uberlândia 11
Warsaw 11
Chengdu 10
Hangzhou 10
Hong Kong 10
San Diego 10
Szekszárd 10
Zurich 10
Athens 9
Delhi 9
Lima 9
Madrid 9
Amsterdam 8
Berlin 8
Curitiba 8
Hamamatsu 8
London 8
Portland 8
Zagreb 8
Brescia 7
Brussels 7
Chicago 7
Girona 7
Lisbon 7
Norwalk 7
Polska 7
Soliera 7
Bad Zwischenahn 6
Barcelona 6
Bethesda 6
Bozeman 6
Catania 6
Gumyojicho 6
Logroño 6
Lublin 6
Matawan 6
Naples 6
Norfolk 6
Osaka 6
Pasto 6
Alaşehir 5
Augsburg 5
Belgrade 5
Canberra 5
Totale 2.868
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 1.196
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 432
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 327
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 294
Aspetti medico legali e concetto di responsabilità in medicina d'emergenza - urgenza 266
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 263
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 212
Diagnosi e terapia del carcinoma corticosurrenalico 182
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 176
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 162
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 130
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 120
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 116
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 115
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 111
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma 105
Mitotane: new facts for an old drug 102
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 89
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 88
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 81
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 76
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 64
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 63
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question 59
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation 50
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 49
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 42
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 39
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion 36
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 35
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma 33
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 29
Adrenal cortical carcinoma: mitotane and beyond 26
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. 25
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 25
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 25
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 14
Totale 5.257
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.154
article - articoli 0
book - libri 0
conference - conferenze 2.079
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 54 28 47 66 48 37 47
2020/2021699 59 35 63 37 43 43 47 54 39 70 101 108
2021/2022914 74 50 58 76 82 65 67 68 62 88 130 94
2022/20231.083 92 107 50 86 80 176 66 82 125 47 85 87
2023/2024904 86 125 62 85 83 76 47 76 28 74 86 76
2024/2025725 61 88 105 117 262 92 0 0 0 0 0 0
Totale 5.257